New Perspectives on the Pathogenesis and Treatment of Alzheimer's Disease
Pharmacy Times Office of Continuing Professional Education
New Perspectives on the Pathogenesis and Treatment of Alzheimer's Disease
Yvette C. Terrie, BSPharm, RPh
Clinical Pharmacist/Consultant Pharmacist
Haymarket, Virginia
Yvette C. Terrie, BSPharm, RPh, has no relevant affiliations or financial relationships to disclose related to this activity.
Editorial support for this continuing education activity was provided by Elena Beyzarov, PharmD, who has no relevant affiliations or financial relationships to disclose related to this activity.
Judy V. Lum, MPA; Ann C. Lichti, CCMEP; and Donna Fausak of the Pharmacy Times Office of Continuing Professional Education have no relevant affiliations or financial relationships to disclose related to this activity.
Bea Riemschneider, Jennifer Barrio, and David Allikas of Pharmacy Times Editorial have no relevant affiliations or financial relationships to disclose related to this activity.
Educational Objectives
Upon completion of this educational activity, participants should be able to:
- Describe the basic etiology and pathophysiology associated with Alzheimer's disease (AD).
- Evaluate the epidemiology of AD, as well as its types, stages, and risk factors.
- Examine the pharmacist's role in counseling patients and caregivers on AD and related issues.
- Discuss the latest research and clinical developments with regard to AD.
Target audience: Pharmacists
Type of activity: Knowledge
Original Activity Title: The Pharmacist's Role in the Management of Alzheimer's Disease
Original Dates of Certification: January 1, 2007, to January 1, 2010
Date of Review: March 15, 2012. This activity has undergone a content review and was updated to reflect the latest research and clinical developments regarding AD.
Current Release date: April 10, 2012
Current Expiration date: April 10, 2014
Estimated time to complete activity: 2 hours
Fee: This lesson is free online
Click here to view this activity.
